BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.45% | -18.12% | -32.18% | -5.53% | 27.39% |
| Total Depreciation and Amortization | -58.33% | -20.00% | -6.25% | -5.88% | -10.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.22% | -1.48% | 0.74% | 2.28% | -1.50% |
| Change in Net Operating Assets | -75.71% | 244.76% | 51.42% | -2,246.30% | -88.03% |
| Cash from Operations | -1.92% | 37.12% | 1.46% | -99.01% | 14.25% |
| Capital Expenditure | -- | -- | 50.00% | 33.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 50.00% | 33.33% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 699.53% | 443.59% | -99.46% | 289.29% | 26.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.50% | 33.33% | 97.77% | -1,635.48% | 31.11% |
| Cash from Financing | 757.65% | 1,206.67% | -99.75% | 242.59% | 29.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.18% | 44.43% | -172.93% | 643.43% | 406.49% |